Research & clinical studies

The science behind Béa's insemination treatment

Since 2020, we’ve set out to create a new gold standard in fertility care through evidence-based, scientifically-backed and research-driven treatments.

Béa efficacy rate

39.28% pregnancy rate over 3 treatment cycles¹

Dive into the results from our first research study

Why the insemination treatment helps you conceive

Find out the science behind our insemination  kit including how our bespoke Béa Applicator and cervical cap work together to deliver semen directly to the cervix, maximizing your chances of conceiving. 

Delivering 3.23x more sperm to the cervix than timed intercourse alone²
How Béa compares

We believe that fertility care should be proactive, accessible and emotionally supportive at every step of the journey. Here’s how we stack up.

Want to find out if a Béa treatment plan is right for you?

The Béa Applicator is designed to enhance your body’s natural in-built systems

39.28% pregnancy rate¹

Our patented Béa Applicator places and holds semen directly onto the cervix, and the Béa Kit guides you through every stage of the menstrual cycle for conceiving.

7-inch stem length

Bodies vary. The Béa Applicator’s stem is long enough to reach the cervix of every body, delivering up to 3.23x more sperm to the cervix than timed intercourse.²

Better than a syringe

Cervical cap insemination is known to have a significantly higher pregnancy rate per cycle (15.2%) compared to straw or syringe insemination (5.9%).⁵

Eliminates semen backflow

The Béa Applicator minimises the contact of semen in the vagina (where pH can reduce sperm quality), eliminates semen backflow and increases exposure time to cervical mucus.

Suited to those with male factor infertility

Our applicator bypasses the vaginal canal, protecting sperm and giving it a better chance to reach the cervix. Most other devices deposit in the canal, where bacteria can be harmful.

We know how hard, stressful and lonely trying to conceive can feel. We’re here to change that.

felt less alone when able to talk to someone about their concerns⁶

That's why support and care is at the center of the Béa insemination treatment. We're here to guide, support and be on hand for advice whenever you need us.

83% of people experience the emotional rollercoaster of trying to conceive⁶

We’re here to take the pressure off, remove the guesswork and alleviate any stress. Our guidance, care and support is designed to be your shoulder to lean on, your glimmer of hope when things feel tough and your helpful confidante whenever you have a question. 

How to use the Béa Applicator
Always at Béa
Through 4 years of research, we’ve created a treatment that sets the gold standard for at-home fertility care.

Clarity and confidence from
the moment you purchase

Béa sets you up for success with a personalized plan and virtual care from day 1.

Optimize your chances with scientifically-backed resources and tools

Our guides, blogs and hub are designed to empower you with fertility knowledge, advice and tips.

Created and developed by experts with you in mind

An insemination treatment designed and tested for over 4 years with leading gynecologists and embryologists.

Notes and sources
1. 39.28% pregnancy rate among 56 Béa users who completed up to three Béa insemination treatment cycles and reported outcomes between June–Dec 2023. Average age 37. Internal observational data; no control group. Results vary and are not guaranteed. “Pregnancy rate” refers to reported pregnancies during/after treatment; it is not a live-birth rate.
2. Based on a postcoital test of another cervical-cap device vs intercourse: 11/13 (85%) showed higher cervical-mucus sperm scores; among responders, average 3.23× (Pelekanos, 2015). Not Béa; no syringe comparison. PCT scores are semi-quantitative and don’t predict pregnancy. Results vary.
3. ~$1,363 per cycle (Manfredi et al., 2023). Actual costs vary by age, health, and clinic.
4. 31% success rate over 3 cycles from a limited NZ study with ovarian stimulation (Farhi et al., 2017). Results vary by age, diagnosis, and sperm quality. Béa's internal data and this study are from different sources and populations; not a direct comparison.
5. Based on a randomized cross-over study comparing cervical cap insemination (15.2% pregnancies per cycle) with syringe-based intracervical insemination (5.9%) (Flierman et al., 2017). The Béa device was not used in this study. Pregnancy rates are per cycle and results vary.
6. Results from Béa's own qualitative, interview-based research made up of 30 US-based consumers who are currently TTC.